Vanda Pharmaceuticals (VNDA) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to -$263.8 million.
- Vanda Pharmaceuticals' Enterprise Value rose 2957.38% to -$263.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$263.8 million, marking a year-over-year increase of 2957.38%. This contributed to the annual value of -$263.8 million for FY2025, which is 2957.38% up from last year.
- As of Q4 2025, Vanda Pharmaceuticals' Enterprise Value stood at -$263.8 million, which was up 2957.38% from -$293.8 million recorded in Q3 2025.
- In the past 5 years, Vanda Pharmaceuticals' Enterprise Value registered a high of -$263.8 million during Q4 2025, and its lowest value of -$501.5 million during Q1 2023.
- Over the past 5 years, Vanda Pharmaceuticals' median Enterprise Value value was -$395.3 million (recorded in 2021), while the average stood at -$401.8 million.
- Per our database at Business Quant, Vanda Pharmaceuticals' Enterprise Value tumbled by 2107.93% in 2021 and then skyrocketed by 2957.38% in 2025.
- Vanda Pharmaceuticals' Enterprise Value (Quarter) stood at -$432.8 million in 2021, then decreased by 7.87% to -$466.9 million in 2022, then rose by 16.83% to -$388.3 million in 2023, then rose by 3.51% to -$374.6 million in 2024, then increased by 29.57% to -$263.8 million in 2025.
- Its last three reported values are -$263.8 million in Q4 2025, -$293.8 million for Q3 2025, and -$325.6 million during Q2 2025.